We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

There are currently more than 30 HIV vaccine candidates in trial around the globe, but estimates of global demand for a vaccine have so far been based on vaccine characteristics that do not reflect the ones in development.

A realistic assessment of the potential public and private demand for an HIV vaccine is important, argue Robert Hecht and Chutima Suraratdecha.

First, it would help persuade governments and industry to fund more research and product development, and would encourage investment from Western donors to compensate for the limited purchasing power of poor developing countries.

Second, it would give the pharmaceutical industry a better idea of the scale of manufacturing facilities needed to ensure sufficient production of the vaccine.

Third, it would help to inform research decisions: if a vaccine is only partially effective, can only be administered to adolescents and adults, or is very expensive, its demand and further development are likely to be affected.

Finally, such an assessment would guide government plans for vaccination programmes and strengthen vaccine delivery systems.

It is critical, say the authors, that a renewed effort be made to develop models that reflect the key drivers of demand and can be updated in coming years.

Link to full article in PLoS Medicine